scorecardresearch
Add as a preferred source on Google
Saturday, November 22, 2025
TopicPfizer vaccine

Topic: Pfizer vaccine

Pfizer shots, prior infection could protect better against Omicron, South African scientists say

Scientists, in a preprint, estimated 73% protection against symptomatic disease from Omicron and 95% against severe infections for those who had been vaccinated & previously infected.

Booster shot of Pfizer vaccine can cut mortality from Delta variant by 90%, says Israeli study

Data culled from 54-day study period involving 8 lakh participants aged over 50, some of whom had got the booster shot.

Falsified data, inadequately trained vaccinators: BMJ flags Pfizer vaccine trial ‘violations’

An estimated 418.41 million doses of the Pfizer vaccine have been administered across the world, as of 3 November. India hasn’t given approval to the vaccine.

US authorises Pfizer Covid vaccine for children aged 5 to 11

President Joe Biden’s administration has said they have enough vaccines for all 28 million kids in the 5 to 11 age group, and they are ready to ship the shots.

Pfizer-BioNTech booster shot 95.6% effective against Covid in large trial

The efficacy of the third shot was consistent across age groups and among people with pre-existing conditions, Pfizer and BioNTech said in a statement.

Pfizer Covid vaccine safe for kids aged 5-11 yrs, shows robust antibody response, trail finds

Pfizer and BioNTech SE said phase 1/2/3 trial initially enrolled up to 4,500 kids between 6 months to 11 years in the US, Finland, Poland & Spain from over 90 clinical trial sites.

Covid versus vaccine immunity — data on Pfizer shot kicks up great debate again

New data shows CDC erred in telling people that vaccine-induced immunity is better than that acquired from infection. But point of vaccine is to cut risk of infection in the first place.

80% Covid immunity lost in 6 months in some after second Pfizer vaccine dose, US study finds

The yet-to-be published study, by Case Western Reserve University and Brown University, studied blood samples of 120 nursing home residents and 92 health care workers.

Second mRNA vaccine shot safe for people who had allergic reactions to first shot: US study

Of the 189 patients who participated in the study, 130 received the Moderna vaccine, while 59 got the Pfizer-BioNTech vaccine. Second dose was administered to 159 subjects.

Why India should get Pfizer vaccine to inoculate its people, reserve doses for pregnant women

India should get the Pfizer vaccine because it has two sets of the population who will benefit enormously from this vaccine.

On Camera

Trump’s 28 points for Ukraine add up to a no-go at peace

Two questions are pertinent: Why does the Trump administration keep making the same mistakes on the peace proposal? And what does a hurried peace plan mean on the ground?

At Charcha 2025: Local entrepreneurship, not just big IT, will drive next wave of distributed AI work

While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.

Tejas fighter aircraft crashes at Dubai Air Show, IAF confirms pilot’s death

This is the second such incident after a Light Combat Aircraft (LCA) Tejas had crashed into a hostel on the outskirts of Jaisalmer in March last year.

INDIA has a Congress-sized hole. And the fix begins with a little humility

Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.